Skip to main content
SpringerLink
Log in

PROTEIN THERAPY

Precision cancer targeting with antibody pairs

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Logic-gated monoclonal antibodies have been designed to improve safety and efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: HexElect technology.

References

  1. Christian, B. A. & Lin, T. S. Semin. Hematol. 45, 95–103 (2008).

    Article  CAS  Google Scholar 

  2. Alinari, L. et al. Oncogene 26, 3644–3653 (2007).

    Article  CAS  Google Scholar 

  3. Oostindie, S. C. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01384-1 (2022).

    Article  PubMed  Google Scholar 

  4. Lajoie, M. J. et al. Science 369, 1637–1643 (2020).

    Article  CAS  Google Scholar 

  5. Roybal, K. T. et al. Cell 164, 770–779 (2016).

    Article  CAS  Google Scholar 

  6. Banaszek, A. et al. Nat. Commun. 10, 5387 (2019).

    Article  Google Scholar 

  7. Diebolder, C. A. et al. Science 343, 1260–1263 (2014).

    Article  CAS  Google Scholar 

  8. Oostindie, S. C. et al. Haematologica 104, 1841–1852 (2019).

    Article  CAS  Google Scholar 

  9. Macor, P., Capolla, S. & Tedesco, F. Front. Immunol. 9, 2203 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Seagen, Inc., Bothell, WA, USA

    Robert T. Lawrence & Peter D. Senter

Authors
  1. Robert T. Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter D. Senter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Robert T. Lawrence or Peter D. Senter.

Ethics declarations

Competing interests

The authors are employed by Seagen, Inc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lawrence, R.T., Senter, P.D. Precision cancer targeting with antibody pairs. Nat Biotechnol 40, 1434–1435 (2022). https://doi.org/10.1038/s41587-022-01401-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01401-3

  • Springer Nature America, Inc.

Search

Navigation